Hematopoietic cell transplantation for sialidosis type I.
Mol Genet Metab Rep
; 30: 100832, 2022 Mar.
Article
in En
| MEDLINE
| ID: mdl-35242566
ABSTRACT
We report the clinical and laboratory follow-up data of an adolescent female with Type I Sialidosis who underwent bone marrow transplant (BMT). After BMT, plasma and urine biomarkers responded concurrently with engraftment. Neuropsychiatry data showed preservation in some domains, but she did have overall decline in motor performance. Sialidosis is a very rare lysosomal condition, and we believe this to be the first report of a case of Type I Sialidosis undergoing BMT.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Mol Genet Metab Rep
Year:
2022
Document type:
Article
Affiliation country: